AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7797651 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation plus PHEP
Number of subjects: 0
Study 7797651 — intervention group
Group type: EXPERIMENTAL
Intervention: PHEP only
Number of subjects: 0
Study 7797651 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 2309645 — intervention group
Group type: EXPERIMENTAL
Intervention: Mackerel paste (135 g daily)
Number of subjects: 42
Study 2309645 — intervention group
Group type: COMPARATOR
Intervention: Meat paste (control group)
Number of subjects: 42
Study 391240 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetraxate (CET) hydrochloride
Number of subjects: 234
Study 391240 — intervention group
Group type: COMPARATOR
Intervention: Gefarnate (control)
Number of subjects: 234
Study 31599661 — intervention group
Group type: EXPERIMENTAL
Intervention: Snack at Night (SN; n = 13)
Number of subjects: 39
Study 31599661 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal at Night (MN; n= 12)
Number of subjects: 39
Study 31599661 — intervention group
Group type: COMPARATOR
Intervention: No Eating at Night (NE; n = 14)
Number of subjects: 39
Study 27545497 — intervention group
Group type: EXPERIMENTAL
Intervention: TDF 300mg once daily
Number of subjects: 280
Study 27545497 — intervention group
Group type: COMPARATOR
Intervention: FTC 200mg and TDF 300mg once daily
Number of subjects: 280
Study 26049257 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS (1 mA, 13 min, on the motor primary cortex) applied before training
Number of subjects: 12
Study 26049257 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 12
Study 26049257 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS applied during training
Number of subjects: 12
Study 26049257 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS applied after training
Number of subjects: 12
Study 25143985 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrocautery for coagulation
Number of subjects: 0
Study 25143985 — intervention group
Group type: COMPARATOR
Intervention: Nonintervention group
Number of subjects: 0
Study 22168961 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized fentanyl citrate (50 mcg)
Number of subjects: 12
Study 19544820 — intervention group
Group type: EXPERIMENTAL
Intervention: Flowable composite (Flowable Filtek Supreme XT) or flowable composite (Dyract Flow) as gingival liners
Number of subjects: 144
Study 19544820 — intervention group
Group type: EXPERIMENTAL
Intervention: Packable composite (Filtek P60) or nano‐filled composite (Universal Filtek Supreme XT) with flowable liners
Number of subjects: 144
Study 19544820 — intervention group
Group type: COMPARATOR
Intervention: Light curing technology (LED)
Number of subjects: 144
Study 19544820 — intervention group
Group type: COMPARATOR
Intervention: Light curing technology (QTH)
Number of subjects: 144
Study 17949629 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive monitoring of cardiovascular risk (CVR) factors
Number of subjects: 188
Study 17949629 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 188
Study 15346266 — intervention group
Group type: EXPERIMENTAL
Intervention: PTA
Number of subjects: 124
Study 15346266 — intervention group
Group type: COMPARATOR
Intervention: Palmaz stent placement
Number of subjects: 124
Study 11748333 — intervention group
Group type: EXPERIMENTAL
Intervention: Population-based random sample reference range
Number of subjects: 484
Study 11748333 — intervention group
Group type: COMPARATOR
Intervention: Unselected volunteers reference range
Number of subjects: 484
Study 11748333 — intervention group
Group type: COMPARATOR
Intervention: Selected healthy subset reference range
Number of subjects: 484
Study 11913408 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous conjugated equine estrogens (CE) + continuous medroxyprogesterone acetate (MPA) 2.5 mg (Group A)
Number of subjects: 100
Study 11913408 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous conjugated equine estrogens (CE) + continuous medroxyprogesterone acetate (MPA) 5 mg (Group B)
Number of subjects: 100
Study 11913408 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Group E)
Number of subjects: 100
Study 11913408 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous medroxyprogesterone acetate (MPA) 5 mg (Group C)
Number of subjects: 100
Study 11913408 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous medroxyprogesterone acetate (MPA) 10 mg (Group D)
Number of subjects: 100
Study 7547078 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant IFN alpha‐2b (3 x 10(6) IU 3 times weekly)
Number of subjects: 150
Study 7547078 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 150
Study 2675757 — intervention group
Group type: EXPERIMENTAL
Intervention: Norfloxacin (800 mg single dose)
Number of subjects: 55
Study 2675757 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (5-day treatment)
Number of subjects: 55
Study 26369 — intervention group
Group type: EXPERIMENTAL
Intervention: Suxamethonium
Number of subjects: 0
Study 26369 — intervention group
Group type: EXPERIMENTAL
Intervention: Fazadinium
Number of subjects: 0
Study 26369 — intervention group
Group type: COMPARATOR
Intervention: Pancuronium
Number of subjects: 0
Study 26369 — intervention group
Group type: COMPARATOR
Intervention: Tubocurarine
Number of subjects: 0
Study 30626566 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth app (app-only)
Number of subjects: 244
Study 30626566 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth app plus physical activity tracker and digital scale (app-plus)
Number of subjects: 244
Study 30626566 — intervention group
Group type: COMPARATOR
Intervention: Information-only control group
Number of subjects: 244
Study 30626566 — intervention group
Group type: EXPERIMENTAL
Intervention: All participants
Number of subjects: 244
Study 26746219 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary guidelines compliance
Number of subjects: 165
Study 26746219 — intervention group
Group type: COMPARATOR
Intervention: Control diet (traditional British diet)
Number of subjects: 165
Study 26650491 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.8 mL of 2% lidocaine for inferior alveolar nerve block (IANB)
Number of subjects: 177
Study 26650491 — intervention group
Group type: COMPARATOR
Intervention: Control group (mild preoperative pain)
Number of subjects: 177
Study 23645690 — intervention group
Group type: EXPERIMENTAL
Intervention: CHVP-interferon plus rituximab
Number of subjects: 358
Study 23645690 — intervention group
Group type: COMPARATOR
Intervention: CHVP-interferon
Number of subjects: 358
Study 16413328 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfuzosin 10 mg once daily for 4 weeks
Number of subjects: 100
Study 16413328 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 15072886 — intervention group
Group type: EXPERIMENTAL
Intervention: Dutasteride
Number of subjects: 2802
Study 15072886 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2802
Study 10813541 — intervention group
Group type: COMPARATOR
Intervention: 7 L leukapheresis
Number of subjects: 60
Study 10813541 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 L leukapheresis
Number of subjects: 60
Study 8856576 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acids (L-alanine, L-glutamine, L-phenylalanine, L-proline)
Number of subjects: 15
Study 8856576 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose
Number of subjects: 15
Study 8856576 — intervention group
Group type: EXPERIMENTAL
Intervention: L-alanine
Number of subjects: 15
Study 8856576 — intervention group
Group type: COMPARATOR
Intervention: Acarbose pretreatment
Number of subjects: 15
Study 1478771 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment for 70 weeks
Number of subjects: 27
Study 1478771 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment for 36 weeks followed by active treatment for 30 weeks (crossover group)
Number of subjects: 27
Study 6143669 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg zetidoline
Number of subjects: 8
Study 6143669 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 30586704 — intervention group
Group type: EXPERIMENTAL
Intervention: Permanent polymer zotarolimus-eluting stent (PP-ZES)
Number of subjects: 1502
Study 30586704 — intervention group
Group type: COMPARATOR
Intervention: Polymer-free amphilimus-eluting stent (PF-AES)
Number of subjects: 1502
Study 29332068 — intervention group
Group type: EXPERIMENTAL
Intervention: Transtympanic steroids (0.5 mL of 10 mg/mL dexamethasone at 24 h prior to surgery)
Number of subjects: 30
Study 29332068 — intervention group
Group type: COMPARATOR
Intervention: Oral steroids (1 mg/kg/day of prednisolone for 6 days prior to surgery)
Number of subjects: 30
Study 29332068 — intervention group
Group type: COMPARATOR
Intervention: Control group (no steroids)
Number of subjects: 30
Study 26198842 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 21
Study 26198842 — intervention group
Group type: EXPERIMENTAL
Intervention: Galactose
Number of subjects: 21
Study 26198842 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy (lisinopril, losartan, atorvastatin)
Number of subjects: 21
Study 23599045 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 (7-36 amide) infusion
Number of subjects: 30
Study 23599045 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 30
Study 21719866 — intervention group
Group type: EXPERIMENTAL
Intervention: HQ system (cleanser, toner, proprietary 4% hydroquinone, exfoliant, and sunscreen) plus 0.05% tretinoin cream
Number of subjects: 61
Study 21719866 — intervention group
Group type: COMPARATOR
Intervention: Standard skin care regimen (cleanser, moisturizer, and sunscreen)
Number of subjects: 61
Study 19423530 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen-alone
Number of subjects: 0
Study 19423530 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen plus progestin
Number of subjects: 0
Study 16467415 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher mean summer temperature (1.3 degrees C increase)
Number of subjects: 3964
Study 16467415 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher mean summer rainfall (33.9 mm increase)
Number of subjects: 3964
Study 15071274 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 103
Study 15071274 — intervention group
Group type: COMPARATOR
Intervention: ICD
Number of subjects: 103
Study 10857374 — intervention group
Group type: EXPERIMENTAL
Intervention: Polarized light exposure
Number of subjects: 6
Study 10857374 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonpolarized light exposure
Number of subjects: 6
Study 10857374 — intervention group
Group type: COMPARATOR
Intervention: Control, dark exposure
Number of subjects: 6
Study 8557151 — intervention group
Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA) 100 mg daily
Number of subjects: 38
Study 8557151 — intervention group
Group type: COMPARATOR
Intervention: Placebo (one tablet daily)
Number of subjects: 38
Study 8557151 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin acetate 3.6 mg (Zoladex depot)
Number of subjects: 38
Study 8557151 — intervention group
Group type: EXPERIMENTAL
Intervention: MPA
Number of subjects: 38
Study 8557151 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 1614351 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention between presentations 1 and 2
Number of subjects: 0
Study 1614351 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention between presentations 2 and 3
Number of subjects: 0
Study 1614351 — intervention group
Group type: COMPARATOR
Intervention: Repeated presentations alone (Control)
Number of subjects: 0
Study 3903533 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone 25 mg
Number of subjects: 10
Study 3903533 — intervention group
Group type: COMPARATOR
Intervention: Naltrexone 0 mg (placebo)
Number of subjects: 10
Study 3903533 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone 50 mg
Number of subjects: 10
Study 3903533 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone 100 mg
Number of subjects: 10
Study 30672317 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (two sessions per week for three months)
Number of subjects: 216
Study 30672317 — intervention group
Group type: COMPARATOR
Intervention: Citicoline (100 mg three times daily for three months)
Number of subjects: 216
Study 30672317 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 216
Study 30672317 — intervention group
Group type: COMPARATOR
Intervention: Citicoline
Number of subjects: 216
Study 30672317 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture and Citicoline
Number of subjects: 216
Study 30027607 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergaming (video gaming that involves physical activity) for 24 weeks, 1 hour per session, three times a week, with telehealth coaching.
Number of subjects: 46
Study 30027607 — intervention group
Group type: COMPARATOR
Intervention: Control group received exergames after the final clinic visit.
Number of subjects: 46
Study 27306732 — intervention group
Group type: EXPERIMENTAL
Intervention: Executive function training focusing on inhibitory control (IC) and mindfulness integration
Number of subjects: 0
Study 27306732 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness training integrated with executive function skills training
Number of subjects: 0
Study 24880524 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness based neuropsychological intervention
Number of subjects: 127
Study 24880524 — intervention group
Group type: COMPARATOR
Intervention: Control group (receiving donepezil)
Number of subjects: 127
Study 24880524 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive stimulation and progressive muscular relaxation (experimental groups)
Number of subjects: 127
Study 21971720 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical thrombectomy using the Solitaire stent
Number of subjects: 87
Study 21971720 — intervention group
Group type: COMPARATOR
Intervention: Local intraarterial thrombolysis using urokinase
Number of subjects: 87
Study 20501914 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 online emergency preparedness training modules
Number of subjects: 52
Study 20501914 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training modules)
Number of subjects: 52
Study 20501914 — intervention group
Group type: EXPERIMENTAL
Intervention: Confidence Survey
Number of subjects: 52
Study 17715032 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive nodal irradiation (PNI) of the mediastinal lymph node drainage (Group A)
Number of subjects: 53
Study 17715032 — intervention group
Group type: COMPARATOR
Intervention: No preventive nodal irradiation (Group B)
Number of subjects: 53
Study 15668838 — intervention group
Group type: EXPERIMENTAL
Intervention: Birth preparation classes (8 sessions during pregnancy)
Number of subjects: 200
Study 15668838 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 200
Study 12090385 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) for hypochondriasis
Number of subjects: 0
Study 12090385 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) for body dysmorphic disorder (BDD)
Number of subjects: 0
Study 12090385 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) for undifferentiated somatoform disorders
Number of subjects: 0
Study 12090385 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cognitive-behavioral therapy (CBT) for body dysmorphic disorder (BDD)
Number of subjects: 0
Study 12090385 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cognitive-behavioral therapy (CBT) for somatization disorder
Number of subjects: 0
Study 10740418 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese women (group 1)
Number of subjects: 62
Study 10740418 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup 1a (obese women with upper body obesity)
Number of subjects: 62
Study 10740418 — intervention group
Group type: COMPARATOR
Intervention: Healthy women (group 2)
Number of subjects: 62
Study 10740418 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese women
Number of subjects: 62
Study 7861218 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen sponge
Number of subjects: 102
Study 7861218 — intervention group
Group type: COMPARATOR
Intervention: Control (no collagen sponge)
Number of subjects: 102
Study 1773485 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125% bupivacaine
Number of subjects: 0
Study 1773485 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine
Number of subjects: 0
Study 1773485 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 7021070 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg flurbiprofen daily
Number of subjects: 40
Study 7021070 — intervention group
Group type: COMPARATOR
Intervention: 4.0 g enteric-coated aspirin daily
Number of subjects: 40
Study 7021070 — intervention group
Group type: COMPARATOR
Intervention: Comparison between flurbiprofen and enteric-coated aspirin
Number of subjects: 40
Study 7021070 — intervention group
Group type: COMPARATOR
Intervention: Side effects reported for aspirin
Number of subjects: 40
Study 7021070 — intervention group
Group type: EXPERIMENTAL
Intervention: Side effects reported for flurbiprofen
Number of subjects: 40
Study 7021070 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood urea levels
Number of subjects: 40
Study 31563881 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 4 mg/mL
Number of subjects: 170
Study 31563881 — intervention group
Group type: COMPARATOR
Intervention: Saline 0.9%
Number of subjects: 170
Study 28378851 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard diabetic diet enriched with EPA (120 mg) and DHA (616 mg) twice a day (Study group)
Number of subjects: 90
Study 28378851 — intervention group
Group type: COMPARATOR
Intervention: Standard diabetic diet with placebo (Control group)
Number of subjects: 90
Study 26413530 — intervention group
Group type: EXPERIMENTAL
Intervention: PbtO2-guided management (PbtO2 > 20 mmHg)
Number of subjects: 50
Study 26413530 — intervention group
Group type: COMPARATOR
Intervention: ICP-guided therapy (ICP < 20 mmHg and CPP > 60 mmHg)
Number of subjects: 50
Study 26413530 — intervention group
Group type: EXPERIMENTAL
Intervention: PbtO2-guided management
Number of subjects: 50
Study 24121408 — intervention group
Group type: EXPERIMENTAL
Intervention: High myopia group (15 children)
Number of subjects: 35
Study 24121408 — intervention group
Group type: COMPARATOR
Intervention: Low myopia group (20 children)
Number of subjects: 35
Study 21175271 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensor On
Number of subjects: 153
Study 21175271 — intervention group
Group type: COMPARATOR
Intervention: Sensor Off
Number of subjects: 153
Study 19135905 — intervention group
Group type: EXPERIMENTAL
Intervention: Move to Improve intervention
Number of subjects: 1442
Study 19135905 — intervention group
Group type: COMPARATOR
Intervention: Health education control condition
Number of subjects: 1442
Study 17212759 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical education instruction
Number of subjects: 36
Study 17212759 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking or bicycling to school
Number of subjects: 36
Study 17212759 — intervention group
Group type: EXPERIMENTAL
Intervention: Interscholastic sports
Number of subjects: 36
Study 17212759 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramural sports
Number of subjects: 36
Study 17212759 — intervention group
Group type: EXPERIMENTAL
Intervention: Programs for girls
Number of subjects: 36
Study 17212759 — intervention group
Group type: EXPERIMENTAL
Intervention: After school free play
Number of subjects: 36
Study 17212759 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental support score
Number of subjects: 36
Study 17212759 — intervention group
Group type: COMPARATOR
Intervention: Free/reduced lunch program participation
Number of subjects: 36
Study 17212759 — intervention group
Group type: COMPARATOR
Intervention: Perceived priority of physical education instruction over coaching
Number of subjects: 36
Study 17212759 — intervention group
Group type: COMPARATOR
Intervention: Safety for walking/bicycling to school
Number of subjects: 36
Study 15097262 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorzolamide/Timolol fixed combination
Number of subjects: 492
Study 15097262 — intervention group
Group type: COMPARATOR
Intervention: Brimonidine plus Timolol
Number of subjects: 492
Study 11167641 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin GITS
Number of subjects: 1475
Study 11167641 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin standard (S)
Number of subjects: 1475
Study 11167641 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1475
Study 11167641 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin GITS and Doxazosin standard (S)
Number of subjects: 1475
Study 9270086 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg felodipine daily for 3 months
Number of subjects: 16
Study 9270086 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg felodipine daily for 3 months
Number of subjects: 16
Study 9270086 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg felodipine
Number of subjects: 16
Study 9270086 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg felodipine
Number of subjects: 16
Study 9270086 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine treatment
Number of subjects: 16
Study 7910871 — intervention group
Group type: EXPERIMENTAL
Intervention: drugs and acupuncture
Number of subjects: 143
Study 3355041 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimipramine
Number of subjects: 26
Study 3355041 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 29859377 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Global Impression of Improvement (PGI-I)
Number of subjects: 472
Study 29859377 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician Global Impression Scale of Improvement (CGI-I)
Number of subjects: 472
Study 28551645 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with 5‐fluorouracil, doxifluridine, or uracil‐tegafur for 12 months
Number of subjects: 229
Study 28551645 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 229